TetraLogic Pharmaceuticals Corporation
Latest round
- Series C
Last raised
- May 2011
Total raised
- $70M
Investors
- 12
About TetraLogic Pharmaceuticals Corporation
Founded in 2001 and headquartered in Malvern, US, TetraLogic Pharmaceuticals is dedicated to advancing therapeutic solutions for cancer treatment.2 million shares at a price of USD 7 each. TetraLogic Pharmaceuticals specializes in biopharmaceutical innovations targeting cancer treatments. Their primary focus lies in developing novel therapies that leverage unique biological mechanisms to combat various malignancies.The company plans to utilize the funds from its IPO to enhance research and development initiatives aimed at introducing new therapeutic candidates into clinical trials. TetraLogic is strategically targeting expansion into international markets, including Europe and Asia, by 2017, aiming to bring its innovative treatments to a broader patient population. This approach is aligned with their commitment to address critical health challenges in oncology.
Who invested in TetraLogic Pharmaceuticals Corporation
12 investors across 6 rounds
See all investors in TetraLogic Pharmaceuticals Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TetraLogic Pharmaceuticals Corporation
Who invested in TetraLogic Pharmaceuticals Corporation?
TetraLogic Pharmaceuticals Corporation has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TetraLogic Pharmaceuticals Corporation raised?
TetraLogic Pharmaceuticals Corporation has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did TetraLogic Pharmaceuticals Corporation last raise money?
TetraLogic Pharmaceuticals Corporation's most recent round on record is a Series C, in May 2011.
What does TetraLogic Pharmaceuticals Corporation do?
Founded in 2001 and headquartered in Malvern, US, TetraLogic Pharmaceuticals is dedicated to advancing therapeutic solutions for cancer treatment.
Where is TetraLogic Pharmaceuticals Corporation headquartered?
TetraLogic Pharmaceuticals Corporation is headquartered in Malvern, US.
Which VCs invest in companies like TetraLogic Pharmaceuticals Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at TetraLogic Pharmaceuticals Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like TetraLogic Pharmaceuticals Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.